Lincoln Pharmaceuticals Limited

BSE:531633 Stok Raporu

Piyasa değeri: ₹13.5b

Lincoln Pharmaceuticals Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 5/6

Lincoln Pharmaceuticals has been growing earnings at an average annual rate of 13.2%, while the Pharmaceuticals industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 9.4% per year. Lincoln Pharmaceuticals's return on equity is 16.5%, and it has net margins of 16.5%.

Anahtar bilgiler

13.2%

Kazanç büyüme oranı

13.2%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi17.5%
Gelir büyüme oranı9.4%
Özkaynak getirisi16.5%
Net Marj16.5%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Lincoln Pharmaceuticals nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

BSE:531633 Gelir, gider ve kazançlar (INR Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 245,9229801,0540
31 Mar 245,8059331,0740
31 Dec 235,5058731,0660
30 Sep 235,3788081,0360
30 Jun 235,2257699670
31 Mar 235,1037299810
31 Dec 225,0047141,0500
30 Sep 224,8666749480
30 Jun 224,7346677410
31 Mar 224,7216948520
31 Dec 214,4917098520
30 Sep 214,4406688190
30 Jun 214,4266476480
31 Mar 214,2426237570
31 Dec 204,2315867100
30 Sep 204,0685607150
30 Jun 203,9355405630
31 Mar 203,8655147560
31 Dec 193,8735107060
30 Sep 193,7334927110
30 Jun 193,6324535360
31 Mar 193,6614876670
31 Dec 183,5424706750
30 Sep 183,2384956790
30 Jun 183,1094585350
31 Mar 183,6063466620
31 Dec 174,4632815500
30 Sep 174,3642315070
30 Jun 174,0632064970
31 Mar 173,6032815060
31 Dec 163,6503015220
30 Sep 163,9953014900
30 Jun 164,2452813320
31 Mar 164,0022373710
31 Dec 153,5042195520
30 Sep 153,1001805240
30 Jun 152,9261834940
31 Mar 152,6611502350
31 Dec 142,5451354200
30 Sep 142,4201424220
30 Jun 142,1811061840
31 Mar 142,1071074280
31 Dec 132,0111404280

Kaliteli Kazançlar: 531633 has high quality earnings.

Büyüyen Kar Marjı: 531633's current net profit margins (16.5%) are higher than last year (14.7%).


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 531633's earnings have grown by 13.2% per year over the past 5 years.

Büyüme Hızlandırma: 531633's earnings growth over the past year (27.4%) exceeds its 5-year average (13.2% per year).

Kazançlar vs. Sektör: 531633 earnings growth over the past year (27.4%) exceeded the Pharmaceuticals industry 19.1%.


Özkaynak Getirisi

Yüksek ROE: 531633's Return on Equity (16.5%) is considered low.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin